Bjarnsholt, T. et al. The importance of understanding the infectious microenvironment. Lancet Infect. Dis. 22, e88–e92 (2022).
Balaban, N. Q. et al. Definitions and guidelines for research on antibiotic persistence. Nat. Rev. Microbiol. 17, 441–448 (2019).
Claudi, B. et al. Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158, 722–733 (2014).
Cunrath, O. & Bumann, D. Host resistance factor SLC11A1 restricts Salmonella growth through magnesium deprivation. Science 366, 995–999 (2019).
Steeb, B. et al. Parallel exploitation of diverse host nutrients enhances Salmonella virulence. PLoS Pathog. 9, e1003301 (2013).
Doern, G. V. & Brecher, S. M. The clinical predictive value (or lack thereof) of the results of in vitro. J. Clin. Microbiol. 49, S11–S14 (2011).
WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance (World Health Organization, 2024).
Newson, J. P., Gaissmaier, M. S., McHugh, S. C. & Hardt, W. D. Studying antibiotic persistence in vivo using the model organism Salmonella Typhimurium. Curr. Opin. Microbiol. 70, 102224 (2022).
Bumann, D. Heterogeneous host-pathogen encounters: act locally, think globally. Cell Host Microbe 17, 13–19 (2015).
Fang, F. C., Frawley, E. R., Tapscott, T. & Vazquez-Torres, A. Bacterial stress responses during host infection. Cell Host Microbe 20, 133–143 (2016).
Liu, X. et al. Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling. BMC Vet. Res. 17, 212 (2021).
Li, J. et al. Tissue compartmentalization enables Salmonella persistence during chemotherapy. Proc. Natl Acad. Sci. USA 118, e2113951118 (2021).
Dobinson, H. C. et al. Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model. Clin. Infect. Dis. 64, 1066–1073 (2017).
Wang, E., Bergeron, Y. & Bergeron, M. G. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia. J. Antimicrob. Chemother. 55, 721–726 (2005).
Dorr, T., Lewis, K. & Vulic, M. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 5, e1000760 (2009).
Dorr, T., Vulic, M. & Lewis, K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8, e1000317 (2010).
Helaine, S. et al. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343, 204–208 (2014).
Pontes, M. H. & Groisman, E. A. Slow growth determines nonheritable antibiotic resistance in Salmonella enterica. Sci. Signal. 12, eaax3938 (2019).
Chen, S. et al. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials. Antimicrob. Agents Chemother. 51, 535–542 (2007).
Bergmiller, T. et al. Biased partitioning of the multidrug efflux pump AcrAB–TolC underlies long-lived phenotypic heterogeneity. Science 356, 311–315 (2017).
Aldridge, B. B. et al. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335, 100–104 (2012).
Kaldalu, N. & Tenson, T. Slow growth causes bacterial persistence. Sci. Signal. 12, eaay1167 (2019).
Rotem, E. et al. Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc. Natl Acad. Sci. USA 107, 12541–12546 (2010).
Korch, S. B., Henderson, T. A. & Hill, T. M. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol. Microbiol. 50, 1199–1213 (2003).
Lopatkin, A. J. et al. Bacterial metabolic state more accurately predicts antibiotic lethality than growth rate. Nat. Microbiol. 4, 2109–2117 (2019).
Tuomanen, E., Cozens, R., Tosch, W., Zak, O. & Tomasz, A. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J. Gen. Microbiol. 132, 1297–1304 (1986).
Aldred, K. J., Kerns, R. J. & Osheroff, N. Mechanism of quinolone action and resistance. Biochemistry 53, 1565–1574 (2014).
Wiktor, J. et al. RecA finds homologous DNA by reduced dimensionality search. Nature 597, 426–429 (2021).
Amarh, V., White, M. A. & Leach, D. R. F. Dynamics of RecA-mediated repair of replication-dependent DNA breaks. J. Cell Biol. 217, 2299–2307 (2018).
Lesterlin, C., Ball, G., Schermelleh, L. & Sherratt, D. J. RecA bundles mediate homology pairing between distant sisters during DNA break repair. Nature 506, 249–253 (2014).
Renzette, N. et al. Localization of RecA in Escherichia coli K-12 using RecA-GFP. Mol. Microbiol. 57, 1074–1085 (2005).
Azevedo, N. F. et al. Proposal for a method to estimate nutrient shock effects in bacteria. BMC Res. Notes 5, 422 (2012).
Wiedemann, B. & Kratz, B. in Ciprofloxacin iv. Defining its Role in Serious Infection (ed. Garrard, C.) 13–19 (Springer, 1993).
Mok, W. W. K. & Brynildsen, M. P. Timing of DNA damage responses impacts persistence to fluoroquinolones. Proc. Natl Acad. Sci. USA 115, E6301–e6309 (2018).
Pontes, M. H. & Groisman, E. A. A physiological basis for nonheritable antibiotic resistance. mBio 11, e00817–e00820 (2020).
Norman, A., Hestbjerg Hansen, L. & Sorensen, S. J. Construction of a ColD cda promoter-based SOS–green fluorescent protein whole-cell biosensor with higher sensitivity toward genotoxic compounds than constructs based on recA, umuDC, or sulA promoters. Appl. Environ. Microbiol. 71, 2338–2346 (2005).
Malik, M., Hussain, S. & Drlica, K. Effect of anaerobic growth on quinolone lethality with Escherichia coli. Antimicrob. Agents Chemother. 51, 28–34 (2007).
Hoiseth, S. K. & Stocker, B. A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238–239 (1981).
Michaux, C., Ronneau, S., Giorgio, R. T. & Helaine, S. Antibiotic tolerance and persistence have distinct fitness trade-offs. PLoS Pathog. 18, e1010963 (2022).
Slattery, A., Victorsen, A. H., Brown, A., Hillman, K. & Phillips, G. J. Isolation of highly persistent mutants of Salmonella enterica serovar typhimurium reveals a new toxin–antitoxin module. J. Bacteriol. 195, 647–657 (2013).
Stapels, D. A. C. et al. Salmonella persisters undermine host immune defenses during antibiotic treatment. Science 362, 1156–1160 (2018).
Slate, A. R. et al. Efficacy of enrofloxacin in a mouse model of sepsis. J. Am. Assoc. Lab. Anim. Sci. 53, 381–386 (2014).
Griffin, A. J., Li, L. X., Voedisch, S., Pabst, O. & McSorley, S. J. Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse. Infect. Immun. 79, 1479–1488 (2011).
Jurėnas, D., Fraikin, N., Goormaghtigh, F. & Van Melderen, L. Biology and evolution of bacterial toxin–antitoxin systems. Nat. Rev. Microbiol. 20, 335–350 (2022).
LeRoux, M. & Laub, M. T. Toxin–antitoxin systems as phage defense elements. Annu. Rev. Microbiol. 76, 21–43 (2022).
Ryall, B., Eydallin, G. & Ferenci, T. Culture history and population heterogeneity as determinants of bacterial adaptation: the adaptomics of a single environmental transition. Microbiol. Mol. Biol. Rev. 76, 597–625 (2012).
Ciolli Mattioli, C. et al. Physiological stress drives the emergence of a Salmonella subpopulation through ribosomal RNA regulation. Curr. Biol. 33, 4880–4892.e14 (2023).
Woodward, W. E. Volunteer studies of typhoid fever and vaccines. Trans. R. Soc. Trop. Med. Hyg. 74, 553–556 (1980).
Kaiser, P. et al. Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol. 12, e1001793 (2014).
Giesbrecht, P., Kersten, T., Maidhof, H. & Wecke, J. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62, 1371–1414 (1998).
Davoodi, S., Daryaee, F., Chang, A., Walker, S. G. & Tonge, P. J. Correlating drug-target residence time and post-antibiotic effect: insight into target vulnerability. ACS Infect. Dis. 6, 629–636 (2020).
MacKenzie, F. M. & Gould, I. M. The post-antibiotic effect. J. Antimicrob. Chemother. 32, 519–537 (1993).
Grant, J. & Saux, N. L. Duration of antibiotic therapy for common infections. J. Assoc. Med. Microbiol. Infect. Dis. Can. 6, 181–197 (2021).
Awofisayo-Okuyelu, A., McCarthy, N., Mgbakor, I. & Hall, I. Incubation period of typhoidal salmonellosis: a systematic review and meta-analysis of outbreaks and experimental studies occurring over the last century. BMC Infect. Dis. 18, 483 (2018).
Behr, M. A., Edelstein, P. H. & Ramakrishnan, L. Revisiting the timetable of tuberculosis. BMJ 362, k2738 (2018).
Smit, J. et al. Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implications. Infection 46, 651–658 (2018).
Hasanjani Roushan, M. R. & Ebrahimpour, S. Human brucellosis: an overview. Caspian J. Intern. Med. 6, 46–47 (2015).
Kroger, C. et al. The transcriptional landscape and small RNAs of Salmonella enterica serovar Typhimurium. Proc. Natl Acad. Sci. USA 109, E1277–E1286 (2012).
Bunny, K., Liu, J. & Roth, J. Phenotypes of lexA mutations in Salmonella enterica: evidence for a lethal lexA null phenotype due to the Fels-2 prophage. J. Bacteriol. 184, 6235–6249 (2002).
Craig, M. & Slauch, J. M. Phagocytic superoxide specifically damages an extracytoplasmic target to inhibit or kill Salmonella. PLoS ONE 4, e4975 (2009).
Rollenhagen, C., Sorensen, M., Rizos, K., Hurvitz, R. & Bumann, D. Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proc. Natl Acad. Sci. USA 101, 8739–8744 (2004).
Roos, U., Harkness, R. E. & Braun, V. Assembly of colicin genes from a few DNA fragments. Nucleotide sequence of colicin D. Mol. Microbiol. 3, 891–902 (1989).
Hofinger, C., Karch, H. & Schmidt, H. Structure and function of plasmid pColD157 of enterohemorrhagic Escherichia coli O157 and its distribution among strains from patients with diarrhea and hemolytic–uremic syndrome. J. Clin. Microbiol. 36, 24–29 (1998).
Rollenhagen, C. & Bumann, D. Salmonella enterica highly expressed genes are disease specific. Infect. Immun. 74, 1649–1660 (2006).
Cianfanelli, F. R., Cunrath, O. & Bumann, D. Efficient dual-negative selection for bacterial genome editing. BMC Microbiol. 20, 129 (2020).
Nanchen, A., Schicker, A. & Sauer, U. Nonlinear dependency of intracellular fluxes on growth rate in miniaturized continuous cultures of Escherichia coli. Appl. Environ. Microbiol. 72, 1164–1172 (2006).
de Jong, N. W., van der Horst, T., van Strijp, J. A. & Nijland, R. Fluorescent reporters for markerless genomic integration in Staphylococcus aureus. Sci. Rep. 7, 43889 (2017).
Burian, M. et al. Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J. Infect. Dis. 201, 1414–1421 (2010).
Burton, N. A. et al. Disparate impact of oxidative host defenses determines the fate of Salmonella during systemic infection in mice. Cell Host Microbe 15, 72–83 (2014).
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
Thévenaz, P., Ruttimann, U. E. & Unser, M. A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Process. 7, 27–41 (1998).
Becker, D. et al. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 440, 303–307 (2006).
Volkmer, B. & Heinemann, M. Condition-dependent cell volume and concentration of Escherichia coli to facilitate data conversion for systems biology modeling. PLoS ONE 6, e23126 (2011).
